[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337162-105":59,"doc-detail-337162-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","plasma-circcyp24a1-as-a-novel-biomarker-of-esophageal-squamous-cell-carcinoma-accepted-paper","Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma - Accepted Paper","","A clinical challenge in esophageal squamous cell carcinoma (ESCC) is the lack of practical plasma biomarkers for screening and diagnosis. Circular RNAs have strong potential as cancer biomarkers, and this study evaluates circCYP24A1 as a candidate plasma marker and diagnostic tool for ESCC. RNA sequencing identified upregulated circRNAs; circCYP24A1 was confirmed in ESCC tissues by fluorescence in situ hybridization, then quantified in plasma using qRT-PCR. Functional assays further tested biological roles. Results show circCYP24A1 upregulation in plasma and tissues, association with lymph node metastasis, TNM stage, and prognosis, and diagnostic AUC of 0.94.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/plasma-circcyp24a1-as-a-novel-biomarker-of-esophageal-squamous-cell-carcinoma-accepted-paper/337162/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/plasma-circcyp24a1-as-a-novel-biomarker-of-esophageal-squamous-cell-carcinoma-accepted-paper/337162.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main clinical problem addressed in the study?","Question",{"text":112,"@type":113},"The study targets the lack of applicable plasma biomarkers for screening and diagnosing esophageal squamous cell carcinoma (ESCC).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was circCYP24A1 identified and validated in the study?",{"text":117,"@type":113},"Upregulated circRNAs were found by RNA sequencing, then circCYP24A1 expression was assessed in ESCC tissue microarrays using fluorescence in situ hybridization. Plasma levels were evaluated with qRT-PCR, followed by functional validation through CCK-8, wound healing, trans-well assays, and western blot assays.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic and predictive performance did circCYP24A1 show?",{"text":121,"@type":113},"circCYP24A1 achieved an AUC of 0.94 for diagnosing ESCC and an AUC of 0.76 for predicting lymph node metastasis, with functional loss results supporting its role in promoting EMT and tumor metastasis in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337162,1790143651,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma  \nRuolan Zhang, M. M. 1,2 , Jianlin Liu, M. M.1, Hang Yang, M. M. 1,3, Jinsong Tan, M. M. 1,3, Rong Xiong, M. M.3, Yun Liu, MM3,  \nGang Feng, PhD 1, Guiqin Song, PhD 1,3, and Kang Liu, PhD 1  \nTechnology in Cancer Research & Treatment  \nVolume 23: 1-12  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15330338241295313](DOI: 10.1177/15330338241295313)[ ](DOI: 10.1177/15330338241295313)[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nAbstract  \nBackground: A clinical challenge in esophageal squamous cell carcinoma (ESCC) remains the lack of applicable plasma biomarkers for screening and diagnosis. Circular RNAs (circRNAs) hold great potential as biomarkers for cancer. The study aims to explore acircRNA as a potential plasma biomarker for screening strategies and diagnostic approaches to ESCC. Methods: Upregulated circRNAs were identiﬁed through RNA sequencing, with circCYP24A1 being identiﬁed as the target circRNA. Fluorescence in situ hybridization was employed to detect the expression of circCYP24A1 in ESCC tissue microarrays, aiming to assess the expression of circCYP24A1 in a large population and its correlation with clinical indicators. Subsequently, qRT-PCR analysis was performed on plasma samples from both ESCC patients and healthy controls to evaluate the expression levels of circCYP24A1, exploring its potential as a biomarker. Finally, the functions of circCYP24A1 were validated through CCK-8 assay, wound healing assay, trans-well assays and western blot assays. Results: CircCYP24A1 demonstrated upregulation in both plasma and tissues, exhibiting correlations with lymph node metastasis, TNM staging, and prognosis in ESCC. The circCYP24A1 achieved a perfect area under the curve of 0.94 for the diagnosis of ESCC, and an area under the curve of 0.76 for the prediction of lymph node metastasis. Furthermore, functional loss assays revealed that circCYP24A1 effectively promotes the epithelial-mesenchymal transition and tumor metastasis in vitro. Conclusions: CircCYP24A1 emerges as a potential plasma diagnostic biomarker and a predictive factor for LNM for ESCC.  \nKeywords  \nesophageal squamous cell carcinoma, circular RNA, circCYP24A1, lymph node metastasis, biomarker  \nAbbreviations  \nAUC, Area under the curve; cDNA, Complementary DNA; circRNA, Circular RNA; cSCC, Cutaneous squamous cell carcinoma; CT, Computed tomography; CYP24A1, Cytochrome P450 family 24 subfamily A member 1; EMT, Epithelial-mesenchymal transition; ESCC, Esophageal squamous cell carcinoma; FISH, Fluorescence in situ hybridization; LNM, Lymph node metastasis; PCa, Prostate cancer; qRT-PCR, Quantitative real-time reverse transcription-polymerase chain reaction; RNase R, Ribonuclease R; RNA-seq, RNA sequencing; ROC, Receiver operating characteristic curve; SCC-Ag, Squamous cell carcinoma antigen; TMA, Tissue microarrays  \nReceived: January 22, 2024; Revised: September 26, 2024; Accepted: October 9, 2024.  \n1 Institute of Tissue Engineering and Stem Cells, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong 63700, China  \n2 Department of Laboratory Medicine, North Sichuan Medical College, Nanchong, China  \n3 Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China  \nCorresponding Authors:  \nKang Liu, Institute of Tissue Engineering and Stem Cells, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong 63700, China.  \nEmail: [liukang@nsmc.edu.cn](liukang@nsmc.edu.cn)  \nGuiqin Song, Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong 63700, Chin","cbCainC3BBXDeCxv","https://ap.wps.com/l/cbCainC3BBXDeCxv","pdf",2364993,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What was the main clinical problem addressed in the study?\",\"answer\":\"The study targets the lack of applicable plasma biomarkers for screening and diagnosing esophageal squamous cell carcinoma (ESCC).\"},{\"question\":\"How was circCYP24A1 identified and validated in the study?\",\"answer\":\"Upregulated circRNAs were found by RNA sequencing, then circCYP24A1 expression was assessed in ESCC tissue microarrays using fluorescence in situ hybridization. Plasma levels were evaluated with qRT-PCR, followed by functional validation through CCK-8, wound healing, trans-well assays, and western blot assays.\"},{\"question\":\"What diagnostic and predictive performance did circCYP24A1 show?\",\"answer\":\"circCYP24A1 achieved an AUC of 0.94 for diagnosing ESCC and an AUC of 0.76 for predicting lymph node metastasis, with functional loss results supporting its role in promoting EMT and tumor metastasis in vitro.\"}]","Plasma CircCYP24A1 as a Novel Biomarker of Esophageal Squamous Cell Carcinoma - Accepted Paper | PDF",1790017953,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61cc5d3737a068113e2971d50311039f.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bef4a2bf1f46179fc7848139c5dbaff.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b19b6fb104916221d9ff5e37d07023a.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4371033d779decbfc19410d99ecc7b3d.webp",980,1272]